Health Care Stocks Making Moves On Friday; Premier Health Group, Inc. (PHGRF) (PHGI), Sellas Life Sciences, Teladoc

CORAL GABLES, FL / ACCESSWIRE / November 9, 2018 / Health care become a key issue this year, with 41% of voters saying it was their No. 1 concern in the election, followed by immigration, the economy, and gun control, according to an NBC News exit poll.

Democrats, who pushed a health-care message during midterms, flipped enough seats to take the House majority away from Republicans in Tuesday's election. Now with a Democrat-controlled House and Republican-majority Senate, it is unlikely that Republicans will revive a push to repeal and replace the landmark healthcare law. And investors appear to appreciate the newfound stability to markets that have long been characterized by uncertainty. With these newest developments beginning to emerge, companies in focus today include Premier Health Group, Inc. (PHGRF) (PHGI), SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) and Teladoc Health, Inc. (NYSE: TDOC)

In October, Premier Health Group, Inc. (PHGRF) (PHGI) announced that it has selected Reliq Health Technologies Inc. as its exclusive technology partner. Reliq will be providing Premier's subsidiary, HealthVue, primary care clinics with a HealthVue-branded telemedicine, remote monitoring & AI solution for its clinical staff and more than 100,000 active patients. Premier Health Group, Inc. (PHGRF) (PHGI) is focused on developing innovative approaches that combine human skill-based expertise with emerging technologies for the healthcare industry. The company has recently seen market activity that is higher than average and could be attributed to the company's most recent announcements.

Premier Health Group, Inc. (PHGRF) (PHGI) announced this week that as a part of its expansion plans it will enter the Pharmacy market via acquisition and/or launching a new Canada based pharmacy in H1-2019. With Premier's acquisition of HealthVue Medical Clinics in August, this could be the next phase of growth for the company.

Premier Health Group, Inc. (PHGRF) (PHGI) has already seen strong movement during the early morning session on Thursday and shares managed to briefly hit highs of $0.81 this week.

For More Information On Premier Health Group, Click Here

Sellas Life Sciences Group (SLS) saw its shares gap up during premarket hours on Friday morning. Sellas is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications. This morning Sellas announced data from a preplanned secondary efficacy analysis across human leukocyte antigen (HLA) allele subgroups from the prospective, randomized, single-blinded, controlled Phase 2b independent investigator-sponsored clinical trial of the combination of nelipepimut-S (NeuVax™, NPS) +/- trastuzumab (Herceptin®) targeting HER2 low-expressing breast cancer patient cohorts. The data are being presented at the 33rd Annual Meeting of the Society for Immunotherapy of Cancer (SITC), being held November 7 -11, 2018.

"These data not only confirm the clinical effect of the NPS plus trastuzumab combination in TNBC, which we recently announced at ESMO with a p-value of 0.013 and a 75% relative reduction in the risk of relapse or death, but also positions NPS biologically as an agent that could potentially be used globally, considering the high prevalence of the HLA-A24 allele in populations across the Pacific basin and Asia. We are scheduled to meet with the U.S. regulatory authorities in December 2018 on the most optimal and expeditious development path for NPS in TNBC, and continue to advance ongoing interactions with potential partners," said Dr. Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS.

For More Information On Sellas Life Sciences Group, Click Here

Teladoc Health, Inc. (TDOC) reported earnings this month. Jason Gorevic, Teladoc Health's chief executive officer said, "Teladoc Health delivered very strong third quarter results. We carry significant momentum into the end of the year, as demand for our comprehensive suite of virtual care services is robust across channels and geographies. We have a tremendous growth opportunity in front of us as the entry point into the health care system where individuals can go for guided access to a fully integrated, high-quality care experience."

Teladoc has also announced the appointment of Mark Douglas Smith, MD, MBA, to its board of directors earlier this month. Dr. Smith is a professor of clinical medicine at the University of California at San Francisco (UCSF) and a nationally-recognized health policy and delivery system expert.

"Mark is a distinguished physician and healthcare leader with a passion for assuring access to care for all, and we are pleased to welcome him to the Teladoc Health board," said Jason Gorevic, Teladoc Health CEO. "Mark's accomplished background complements our mission and enduring commitment to transform the care experience."

For More Information On Teladoc, Click Here

What Is Stock Price (

Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for. was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.

At Stock Price (, you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

JSG Communications, LLC, which owns, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of JSG COMMUNICATIONS LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 - 4/1/2018 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $100,000 (CASH) for & were paid "500,000" shares of restricted common shares. We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six month restriction is complete on 4/1/2019 we plan to sell the "500,000" shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for full disclaimer.

Contact Information:

[email protected]


Recent Posts